Zhang Lei portfolio, Q4 2024

HHLR Advisors (Hillhouse) · 13F for the quarter ending Dec 31, 2024

For Q4 2024, HHLR Advisors (Hillhouse) reported $2.9B across 45 US-listed positions, led by ONC (24.3%), BABA (14.4%) and PDD (9.2%). Compared with its filing for Q3 2024, Zhang Lei opened 5 new positions, added to 10, reduced 10 and sold out of 8; 20 positions did not change.

The largest purchase was a new position in WNS Holdings Ltd ($72.6M); the largest sale, a reduction of BABA ($334.1M).

Reported value
$2.9B
Positions
45
In the top 10
86%
Filed
Feb 14
2025

Key facts

13F portfolio value
$2.9BQ4 2024
Positions
45
Largest holding
ONC 24.3%
New positions
5
Sold out
8
Filed
Feb 14, 2025

Holdings as of (Q4 2024), filed with the SEC on . Changes are measured against the filing for Sep 30, 2024. Every tracked investor's Q4 2024 13F.

Bought and sold in Q4 2024

Zhang Lei: buys and sells in Q4 2024
StockMoveSharesSizeOf portfolio
Alibaba Group Holding LtdBABA▼ Reduced 45%−3.94M$334.1M11.6%
Beone Medicines LtdONC▼ Reduced 27%−1.37M$253.5M8.78%
PDD Holdings IncPDD▼ Reduced 43%−2.04M$197.5M6.84%
WNS Holdings Ltdno ticker on file
▲ New+1.53M$72.6M2.51%
Trip.com Group LtdTCOM▼ Reduced 49%−860.59K$59.1M2.05%
Zto Express Cayman IncZTO▼ Reduced 85%−2.57M$50.2M1.74%
Baidu IncBIDU▼ Sold out−300K$31.6M1.09%
Yum China Holdings IncYUMC▼ Sold out−665.86K$30M1.04%
Legend Biotech CorpLEGN▼ Reduced 9.8%−651.95K$21.2M0.73%
H World Group LtdHTHT▼ Sold out−568.61K$21.2M0.73%
Vipshop Holdings LtdVIPS▼ Reduced 5.4%−840.32K$11.3M0.39%
Agora IncAPI▲ New+2.1M$8.7M0.30%
KE Holdings IncBEKE▲ Added 3.6%+392.59K$7.2M0.25%
Futu Holdings LtdFUTU▲ Added 6.4%+67.21K$5.4M0.19%
Taiwan Semiconductor Manufacturing Company LtdTSM▲ Added 120%+23.19K$4.6M0.16%
Zeekr Intelligent Technologyno ticker on file
▼ Sold out−145K$3.2M0.11%
JD.com IncJD▲ Added 5.6%+90K$3.1M0.11%
Global X FDSno ticker on file
▼ Sold out−100K$2.9M0.10%
Kraneshares TrustKWEB▼ Sold out−79.5K$2.7M0.09%
Sohu.com LtdSOHU▼ Reduced 28%−202.92K$2.7M0.09%
Meta Platforms IncMETA▼ Sold out−4K$2.3M0.08%
MSCI IncMSCI▲ New+3.65K$2.2M0.08%
Moodys CorpMCO▲ Added 198%+2.98K$1.4M0.05%
Danaher CorpDHR▲ Added 44%+3.98K$912.5K0.03%
Novabridge BiosciencesNBP▼ Reduced 13%−928.65K$789.4K0.03%
GE AerospaceGE▲ Added 81%+4.62K$769.7K0.03%
Trane Technologies PLCTT▲ Added 210%+1.59K$585.4K0.02%
Lakeshore Biopharma Co Ltdno ticker on file
▼ Sold out−751.79K$512.7K0.02%
Hello Group IncMOMO▲ New+53.59K$413.2K0.01%
Yatsen Holding LtdYSG▼ Reduced 1.5%−101.97K$405.8K0.01%
Lakeshore Biopharma Co Ltdno ticker on file
▲ New+75.18K$259.4K0.01%
Dada Nexus Ltdno ticker on file
▲ Added 17%+100K$121K0.00%
GE Vernova IncGEV▲ Added 1.0%+80$26.3K0.00%

Holdings at the quarter's end

Zhang Lei holdings, Q4 2024
#StockSectorShare of portfolioValueSharesReported priceHeldSince Q3 2024
1Beone Medicines LtdONC · SPONSORED ADSHealth Care24.3%$702.7M3.8M$184.713+ qtrs▼ Reduced 27%
2Alibaba Group Holding LtdBABA · SPONSORED ADSConsumer Discretionary14.4%$414.4M4.89M$84.793+ qtrs▼ Reduced 45%
3PDD Holdings IncPDD · SPONSORED ADSConsumer Discretionary9.17%$264.8M2.73M$96.993+ qtrs▼ Reduced 43%
4NetEase IncNTES · SPONSORED ADSTechnology8.00%$231M2.59M$89.213+ qtrsNo change
5KE Holdings IncBEKE · SPONSORED ADSReal Estate7.19%$207.4M11.26M$18.423+ qtrs▲ Added 3.6%
6Vipshop Holdings LtdVIPS · SPONSORED ADS AConsumer Discretionary6.94%$200.4M14.88M$13.473+ qtrs▼ Reduced 5.4%
7Legend Biotech CorpLEGN · SPONSORED ADSHealth Care6.75%$194.7M5.98M$32.543+ qtrs▼ Reduced 9.8%
8Arrivent Biopharma IncAVBP—4.14%$119.5M4.48M$26.643+ qtrsNo change
9Futu Holdings LtdFUTU · SPON ADS CL AFinancials3.10%$89.5M1.12M$79.993+ qtrs▲ Added 6.4%
10
WNS Holdings Ltdno ticker on file
—2.51%$72.6M1.53M$47.391 qtrNew
11Trip.com Group LtdTCOM · ADSConsumer Discretionary2.17%$62.7M913.84K$68.663+ qtrs▼ Reduced 49%
12JD.com IncJD · SPON ADS CL AConsumer Discretionary2.03%$58.6M1.69M$34.673+ qtrs▲ Added 5.6%
13
Enfusion Incno ticker on file · CL A
—1.78%$51.2M4.98M$10.303+ qtrsNo change
14Cytek Biosciences IncCTKB—1.50%$43.2M6.66M$6.493+ qtrsNo change
15Kiniksa Pharmaceuticals InternationalKNSA · ORD SHS CL AHealth Care1.08%$31.3M1.58M$19.783+ qtrsNo change
16Bridgebio Pharma IncBBIOHealth Care0.97%$28.1M1.02M$27.443+ qtrsNo change
17Yatsen Holding LtdYSG · SPONSORED ADS—0.95%$27.4M6.89M$3.983+ qtrs▼ Reduced 1.5%
18Contineum Therapeutics IncCTNM · CL A—0.34%$9.8M669.34K$14.653+ qtrsNo change
19Agora IncAPI · ADS—0.30%$8.7M2.1M$4.161 qtrNew
20Zto Express Cayman IncZTO · SPONSORED ADS AIndustrials0.30%$8.5M435.93K$19.553+ qtrs▼ Reduced 85%
21Taiwan Semiconductor Manufacturing Company LtdTSM · SPONSORED ADSTechnology0.29%$8.4M42.59K$197.493+ qtrs▲ Added 120%
22Sohu.com LtdSOHU · SPONSORED ADS—0.23%$6.7M510.48K$13.183+ qtrs▼ Reduced 28%
23Novabridge BiosciencesNBP · SPONSORED ADS—0.18%$5.1M5.98M$0.85003+ qtrs▼ Reduced 13%
24Gossamer Bio IncGOSS—0.16%$4.5M4.97M$0.90463+ qtrsNo change
25Sagimet Biosciences IncSGMT—0.11%$3.3M724.8K$4.503+ qtrsNo change
26Aligos Therapeutics IncALGS—0.11%$3M76.25K$39.843+ qtrsNo change
27Danaher CorpDHRHealth Care0.10%$3M13.08K$229.553+ qtrs▲ Added 44%
28Metagenomi IncMGX—0.10%$2.8M777.77K$3.613+ qtrsNo change
29Tuya IncTUYA · SPONSERED ADS—0.10%$2.8M1.56M$1.793+ qtrsNo change
30
Smart SH Global Ltdno ticker on file · ADS
—0.10%$2.8M3.95M$0.70003+ qtrsNo change
31GE Vernova IncGEVIndustrials0.09%$2.6M7.83K$328.933+ qtrs▲ Added 1.0%
32MSCI IncMSCIFinancials0.08%$2.2M3.65K$600.011 qtrNew
33Moodys CorpMCOFinancials0.07%$2.1M4.48K$473.373+ qtrs▲ Added 198%
34Mogu IncMOGU · SPON ADS—0.06%$1.8M847.51K$2.173+ qtrsNo change
35GE AerospaceGEIndustrials0.06%$1.7M10.33K$166.793+ qtrs▲ Added 81%
36
Bright Scholar ED Holdings Ltdno ticker on file · SPON ADS NEW
—0.06%$1.7M988.14K$1.723+ qtrsNo change
37Pacific Biosciences of California IncPACB—0.06%$1.7M918.89K$1.833+ qtrsNo change
38JOYY IncJOYY · ADS REPSTG COM A—0.04%$1.3M30K$41.852 qtrsNo change
39Trane Technologies PLCTT · SHSIndustrials0.03%$863.5K2.34K$369.353+ qtrs▲ Added 210%
40
Dada Nexus Ltdno ticker on file · ADS
—0.03%$847K700K$1.213+ qtrs▲ Added 17%
41Pyxis Oncology IncPYXS—0.02%$596.9K382.61K$1.563+ qtrsNo change
42Hello Group IncMOMO · ADS—0.01%$413.2K53.59K$7.711 qtrNew
43
Lakeshore Biopharma Co Ltdno ticker on file · ORD SHS NEW
—0.01%$259.4K75.18K$3.451 qtrNew
44Uxin LtdUXIN · SPONSORED ADS—0.00%$88.7K19.16K$4.633+ qtrsNo change
45Ridgetech IncRDGT · SHS NEW—0.00%$35.3K20.17K$1.753+ qtrsNo change

By sector

Zhang Lei portfolio by sector, Q4 2024
SectorShare of portfolioValuePositions
Consumer Discretionary34.7%$1B5
Health Care33.2%$959.9M5
Technology8.29%$239.4M2
Real Estate7.18%$207.4M1
Financials3.25%$93.8M3
Industrials0.47%$13.7M4
No sector on file12.9%$372.1M25

Questions and answers

What did Zhang Lei own in Q4 2024?

HHLR Advisors (Hillhouse)'s 13F for Q4 2024 lists 45 positions worth $2.9B. The largest: ONC (24.3%), BABA (14.4%), PDD (9.2%), NTES (8.0%), BEKE (7.2%).

What did Zhang Lei buy in Q4 2024?

The largest purchases, by the shares bought at the quarter-end price the filing implies: WNS Holdings Ltd (new, $72.6M), API (new, $8.7M), BEKE (added, $7.2M), FUTU (added, $5.4M), TSM (added, $4.6M), JD (added, $3.1M).

What did Zhang Lei sell in Q4 2024?

The largest sales: BABA (reduced, $334.1M), ONC (reduced, $253.5M), PDD (reduced, $197.5M), TCOM (reduced, $59.1M), ZTO (reduced, $50.2M), BIDU (sold out, $31.6M).

When was this filing made?

HHLR Advisors (Hillhouse) filed its 13F for the quarter ending Dec 31, 2024 on Feb 14, 2025. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

Learn

Cite this page

Funkfolio, “Zhang Lei portfolio, Q4 2024: HHLR Advisors (Hillhouse) 13F holdings”, data as of 14 February 2025. https://funkfolio.com/gurus/hillhouse/2024-q4

Underlying data: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304) for the period ending Dec 31, 2024.

Source: SEC EDGAR, Form 13F-HR for HHLR Advisors (Hillhouse) (CIK 1762304), period ending Dec 31, 2024, filed Feb 14, 2025. Changes compare share counts with the filing for Sep 30, 2024; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $2.9B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 3 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.